STOCKHOLM, Nov. 3, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced upcoming presentations concerning Nefecon, its lead product ...
In the current study, investigators aimed to assess longitudinal trends in kidney disease-related deaths and temperature in the US. They analyzed data from the 2010-2020 US Centers for Disease Control ...
UNIONDALE, N.Y., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca will present new research spanning the Company’s Cardiovascular, Renal and Metabolism (CVRM) therapy area at the American Society of Nephrology (ASN) ...
WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...
SAN DIEGO--(BUSINESS WIRE)-- DaVita Inc. (NYS: DVA) , a leading provider of kidney care services committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results